David Solit

81PUBLICATIONS
691CO-AUTHORS
Molecular targetsCancer geneticsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (81)

|Sep 10, 2026
Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.

|Aug 27, 2026
A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.

|Jun 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

|May 22, 2026
Prevalence of Germline Pathogenic RET Variants in a Pan-Cancer Patient Population.

|Apr 22, 2026
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.

|Apr 06, 2026
Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial.

Komal Jhaveri, Lisa D Eli, Sara A Hurvitz

Pageof 14

Frequent Collaborators

31 joint publications

Michael F Berger

18 joint publications

Nikolaus Schultz

17 joint publications

Hikmat Al-Ahmadie

15 joint publications

Gopakumar V Iyer